Inovio Pharmaceuticals
(NASDAQ:INO)
$13.99
0.96[7.37%]
At close: Mar 28
$13.99
0[0.00%]
After Hours: 7:13PM EDT
Consensus Rating1
Hold
Highest Price Target1
$40.00
Lowest Price Target1
$1.00
Consensus Price Target1
$10.50

Inovio Pharmaceuticals Stock (NASDAQ:INO), Analyst Ratings, Price Targets, Predictions

Inovio Pharmaceuticals Inc has a consensus price target of $10.5, established from looking at the 15 latest analyst ratings. The last 3 analyst ratings were released from Oppenheimer, RBC Capital, and Oppenheimer on March 8, 2024, March 7, 2024, and January 25, 2024. With an average price target of $18.33 between Oppenheimer, RBC Capital, and Oppenheimer, there's an implied 31.05% upside for Inovio Pharmaceuticals Inc from these 3 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Jan
1
Mar
1
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Oppenheimer
RBC Capital
JMP Securities
Maxim Group
B of A Securities

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Inovio Pharmaceuticals

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
03/08/2024INOBuy Now
Inovio Pharmaceuticals
$13.99185.92%Oppenheimer
Hartaj Singh
$40 → $40MaintainsOutperformGet Alert
03/07/2024INOBuy Now
Inovio Pharmaceuticals
$13.99-21.37%RBC Capital
Gregory Renza
→ $11ReiteratesSector Perform → Sector PerformGet Alert
01/25/2024INOBuy Now
Inovio Pharmaceuticals
$13.99-71.41%Oppenheimer
Hartaj Singh
→ $4UpgradePerform → OutperformGet Alert
01/04/2024INOBuy Now
Inovio Pharmaceuticals
$13.99-92.85%JMP Securities
Roy Buchanan
→ $12Initiates → Market OutperformGet Alert
05/11/2023INOBuy Now
Inovio Pharmaceuticals
$13.99-85.7%RBC Capital
Gregory Renza
→ $24ReiteratesSector Perform → Sector PerformGet Alert
03/02/2023INOBuy Now
Inovio Pharmaceuticals
$13.99-85.7%RBC Capital
Gregory Renza
$36 → $24MaintainsSector PerformGet Alert
11/09/2022INOBuy Now
Inovio Pharmaceuticals
$13.99Maxim Group
Jason McCarthy
DowngradeBuy → HoldGet Alert
11/01/2022INOBuy Now
Inovio Pharmaceuticals
$13.99-85.7%B of A Securities
Geoff Meacham
→ $24DowngradeNeutral → UnderperformGet Alert
08/10/2022INOBuy Now
Inovio Pharmaceuticals
$13.99-78.56%RBC Capital
Gregory Renza
$48 → $36MaintainsSector PerformGet Alert
05/11/2022INOBuy Now
Inovio Pharmaceuticals
$13.99Oppenheimer
Hartaj Singh
DowngradeOutperform → PerformGet Alert
03/02/2022INOBuy Now
Inovio Pharmaceuticals
$13.99-64.26%RBC Capital
Gregory Renza
$72 → $60MaintainsSector PerformGet Alert
01/21/2022INOBuy Now
Inovio Pharmaceuticals
$13.99-28.52%B of A Securities
Geoff Meacham
$96 → $120UpgradeUnderperform → NeutralGet Alert
11/01/2021INOBuy Now
Inovio Pharmaceuticals
$13.99-57.11%RBC Capital
Gregory Renza
$84 → $72MaintainsSector PerformGet Alert
09/10/2021INOBuy Now
Inovio Pharmaceuticals
$13.99-42.82%B of A Securities
Geoff Meacham
$108 → $96DowngradeNeutral → UnderperformGet Alert
06/24/2021INOBuy Now
Inovio Pharmaceuticals
$13.99-35.67%Jefferies
Kelechi Chikere
→ $108Initiates → HoldGet Alert

FAQ

Q

What is the target price for Inovio Pharmaceuticals (INO)?

A

The latest price target for Inovio Pharmaceuticals (NASDAQ: INO) was reported by Oppenheimer on March 8, 2024. The analyst firm set a price target for $40.00 expecting INO to rise to within 12 months (a possible 185.92% upside). 5 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Inovio Pharmaceuticals (INO)?

A

The latest analyst rating for Inovio Pharmaceuticals (NASDAQ: INO) was provided by Oppenheimer, and Inovio Pharmaceuticals maintained their outperform rating.

Q

When was the last upgrade for Inovio Pharmaceuticals (INO)?

A

The last upgrade for Inovio Pharmaceuticals Inc happened on January 25, 2024 when Oppenheimer raised their price target to $4. Oppenheimer previously had a perform for Inovio Pharmaceuticals Inc.

Q

When was the last downgrade for Inovio Pharmaceuticals (INO)?

A

The last downgrade for Inovio Pharmaceuticals Inc happened on November 9, 2022 when Maxim Group changed their price target from N/A to N/A for Inovio Pharmaceuticals Inc.

Q

When is the next analyst rating going to be posted or updated for Inovio Pharmaceuticals (INO)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Inovio Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Inovio Pharmaceuticals was filed on March 8, 2024 so you should expect the next rating to be made available sometime around March 8, 2025.

Q

Is the Analyst Rating Inovio Pharmaceuticals (INO) correct?

A

While ratings are subjective and will change, the latest Inovio Pharmaceuticals (INO) rating was a maintained with a price target of $40.00 to $40.00. The current price Inovio Pharmaceuticals (INO) is trading at is $13.99, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch